Disease/Infection News

RSS

Immune system produces neutralizing antibodies capable of blocking HIV, says study

Scientists seeking to understand how to make an AIDS vaccine have found the cause of a major roadblock. It turns out that the immune system can indeed produce cells with the potential to manufacture powerful HIV-blocking antibodies - but at the same time, the immune system works equally hard to make sure these cells are eliminated before they have a chance to mature.

16 Dec 2009

Physicians need to utilize best practices to treat HAE patients in emergency settings

Hereditary Angioedema (HAE) is an autosomal dominant disease causing acute attacks of intense edema. These attacks can result in life-threatening complications, including asphyxiation.

16 Dec 2009

Chagas disease transmission in Peru linked to migration and urbanization patterns

New research shows how the migration and settlement patterns associated with the rapid urbanization of Peru may link to Chagas disease transmission. The

16 Dec 2009

Post-surgical infections raise healthcare expenditures

Post-surgical infections significantly increase the chance of hospital readmission and death and cost as much as $60,000 per patient, according to Duke University Medical Center researchers who conducted the largest study of its kind to date.

16 Dec 2009

Infectious virus particles can bind to the surface of red blood cells: MHRP researchers

Free infectious HIV-1 is widely thought to be the major form of the virus in the blood of infected persons. U.S. Military HIV Research Program (MHRP) researchers, however, have demonstrated that essentially all of the infectious virus particles can bind to the surface of red blood cells isolated from each of 30 normal (non-infected) human donors.

16 Dec 2009

Drug monitoring may provide alternative treatments for patients with severe H1N1

An international team of Canadian and Spanish scientists have found the first potential immunological clue of why some people develop severe pneumonia when infected by the pandemic H1N1 virus.

16 Dec 2009

Interactive education program to fight against malaria

ONE and Malaria No More announced today they are accepting applications for the first-ever "Malaria Griots" program, a dynamic education course that will train and educate participants to become leaders in the fight against malaria.

16 Dec 2009

Routine tests to patients in community health centers increase HIV screening: UCSF researchers

UCSF researchers have found that routinely offering rapid HIV tests to patients in community health centers can significantly increase the number of patients screened for HIV.

16 Dec 2009

Majority of workers believe swine flu may impact workflow and productivity

Adecco Group North America's latest American Workplace Insights Survey finds that 77% of workers(1) think their workplace will be impacted in some way by the swine flu.

16 Dec 2009

Dendritic cell changes suggest new strategy to identify and treat debilitating lung disease

A new study links chronic obstructive pulmonary disease, or COPD, with increased activity of cells that act as sentinels to activate the body's immune system.

15 Dec 2009

Increased funds lead to 'significant progress' in global malaria fight, WHO report says

WHO's World Malaria Report 2009, which was released on Tuesday, found "increased funding is starting to pay off in the battle against malaria but prevention and treatment must be increased to try to halt the killer disease," Reuters reports (Kelland, 12/15). According to the Associated Press, there were more than 240 million cases of malaria and an estimated 863,000 people, mostly in Africa, died of the disease in 2008 (Cheng, 12/15).

15 Dec 2009

Can-Fite BioPharma to commence Glaucoma Phase II clinical study in Israel

Can-Fite BioPharma, a biotechnology company traded on the Tel Aviv Stock Exchange, announced on December 13 the initiation of the regulatory process for a Glaucoma Phase II clinical study in Israel. Leading Medical Centers in Israel will enroll 44 patients with Ocular Hypertension or Glaucoma for the first segment of the trial, who will be treated for 16 weeks with CF101 or placebo.

15 Dec 2009

Also in Global Health news: Drug trafficking in Kenya; violence in S. Sudan; Uganda bill; sleeping sickness

Drug trafficking and use are fueling the spread of HIV/AIDS in Kenya, according to a recent report by the U.N. Security Council, the Nation reports. "A statement from the council's Presidency currently … states that Afghan heroin was being imported, causing a dramatic increase in heroin addiction and spreading HIV/AIDS in the slums of Nairobi and Mombasa, Kenya's two main cities," the newspaper writes.

15 Dec 2009

Genocea Biosciences to develop Chlamydia trachomatis vaccine with UPMC grant

Genocea Biosciences, a leading vaccine discovery and development company, today announced it has been awarded a grant from the University of Pittsburgh Medical Center’s (UPMC) Sexually Transmitted Infections (STI) Cooperative Research Center for the development of vaccines for Chlamydia trachomatis.

15 Dec 2009

Tibotec Virco Virology BVBA acquires Ground Zero Software's LAB TRACKER HIV EMR system

Tibotec Virco Virology BVBA today announced the acquisition of LAB TRACKER(TM) HIV, a customized electronic medical record (EMR) system, from the company Ground Zero Software. LAB TRACKER(TM) HIV is a full-service, scalable software platform designed to meet the complex disease-management needs of health care providers who are treating people living with HIV/AIDS.

15 Dec 2009

Safe Life increases production of its A400 Series respirators

Safe Life Corp., an innovative antimicrobial company dedicated to developing novel technologies that prevent the spread of infection and disease, announced today that it is ramping production of its comfortable, breathable, A400 Series respirator to help healthcare providers and government agencies address the global shortage of N95 respirators during the H1N1 pandemic.

15 Dec 2009

Dangers of H1N1 flu contaminated touch surfaces tour kicks-off

Dr. Bob Arnot kicks-off a national educational tour on the silent threat of H1N1 flu contaminated touch surfaces and the new biotechnology in EPA-registered SpectraSan 24 that kills bacteria, fungus and viruses including Influenza A (H1N1 or Swine Flu).

15 Dec 2009

Researchers call for continued STI screening in sexually active teenage girls

Half of urban teenage girls may acquire at least one of three common sexually transmitted infections (STI) within two years of becoming sexually active, according to an Indiana University School of Medicine and Regenstrief Institute study.

15 Dec 2009

Protozoan parasite may be the cause for dinosaur extinction

Infectious diseases can be transmitted by sneezing, touching, or - for Tasmanian devils - biting each other on the face, a habit that may have driven the dinosaurs to extinction through the transmission of a protozoan parasite.

15 Dec 2009

Researchers advance in developing a vaccine against AIDS disease

Led by Matthias J. Schnell, Ph.D., director of the Jefferson Vaccine Center, the researchers found that a rabies virus-based vaccine administered to monkeys protected against the simian equivalent of the HIV virus (SIV). The data were published in the journal Vaccine.

15 Dec 2009

Disease/Infection News

Immune system produces neutralizing antibodies capable of blocking HIV, says study

Physicians need to utilize best practices to treat HAE patients in emergency settings

Chagas disease transmission in Peru linked to migration and urbanization patterns

Post-surgical infections raise healthcare expenditures

Infectious virus particles can bind to the surface of red blood cells: MHRP researchers

Drug monitoring may provide alternative treatments for patients with severe H1N1

Interactive education program to fight against malaria

Routine tests to patients in community health centers increase HIV screening: UCSF researchers

Majority of workers believe swine flu may impact workflow and productivity

Dendritic cell changes suggest new strategy to identify and treat debilitating lung disease

Increased funds lead to 'significant progress' in global malaria fight, WHO report says

Can-Fite BioPharma to commence Glaucoma Phase II clinical study in Israel

Also in Global Health news: Drug trafficking in Kenya; violence in S. Sudan; Uganda bill; sleeping sickness

Genocea Biosciences to develop Chlamydia trachomatis vaccine with UPMC grant

Tibotec Virco Virology BVBA acquires Ground Zero Software's LAB TRACKER HIV EMR system

Safe Life increases production of its A400 Series respirators

Dangers of H1N1 flu contaminated touch surfaces tour kicks-off

Researchers call for continued STI screening in sexually active teenage girls

Protozoan parasite may be the cause for dinosaur extinction

Researchers advance in developing a vaccine against AIDS disease

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News